Prins ND, Scheltens P. White matter hyperintensities, cognitive impairment and dementia: an update. Nat Reviews Neurol. 2015;11(3):157–65.
Brickman AM, Muraskin J, Zimmerman ME. Structural neuroimaging in Alzheimer’s disease: do white matter hyperintensities matter? Dialog Clin Neurosci. 2009;11(2):181–90.
Beach TG, Sue LI, Scott S, Intorcia AJ, Walker JE, Arce RA, et al. Cerebral white matter rarefaction has both neurodegenerative and vascular causes and may primarily be a distal axonopathy. J Neuropathol Exp Neurol. 2023;82(6):457–66.
Article CAS PubMed Google Scholar
Gouw AA, Seewann A, van der Flier WM, Barkhof F, Rozemuller AM, Scheltens P, et al. Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations. J Neurol Neurosurg Psychiatry. 2011;82(2):126–35.
Phuah CL, Chen Y, Strain JF, Yechoor N, Laurido-Soto OJ, Ances BM, et al. Association of data-driven white matter hyperintensity spatial signatures with distinct cerebral small Vessel Disease etiologies. Neurology. 2022;99(23):e2535–47.
Article PubMed PubMed Central Google Scholar
Sargurupremraj M, Suzuki H, Jian X, Sarnowski C, Evans TE, Bis JC, et al. Cerebral small vessel disease genomics and its implications across the lifespan. Nat Commun. 2020;11(1):6285.
Article CAS PubMed PubMed Central Google Scholar
Botz J, Lohner V, Schirmer MD. Spatial patterns of white matter hyperintensities: a systematic review. Front Aging Neurosci. 2023;15.
Article PubMed PubMed Central Google Scholar
Habes M, Sotiras A, Erus G, Toledo JB, Janowitz D, Wolk DA, et al. White matter lesions: spatial heterogeneity, links to risk factors, cognition, genetics, and atrophy. Neurology. 2018;91(10):e964–75.
Article PubMed PubMed Central Google Scholar
Jiménez-Balado J, Corlier F, Habeck C, Stern Y, Eich T. Effects of white matter hyperintensities distribution and clustering on late-life cognitive impairment. Sci Rep. 2022;12(1):1955.
Article PubMed PubMed Central Google Scholar
Salvadó G, Brugulat-Serrat A, Sudre CH, Grau-Rivera O, Suárez-Calvet M, Falcon C, et al. Spatial patterns of white matter hyperintensities associated with Alzheimer’s disease risk factors in a cognitively healthy middle-aged cohort. Alzheimers Res Ther. 2019;11(1):12.
Article PubMed PubMed Central Google Scholar
Bernal J, Schreiber S, Menze I, Ostendorf A, Pfister M, Geisendörfer J, et al. Arterial hypertension and β-amyloid accumulation have spatially overlapping effects on posterior white matter hyperintensity volume: a cross-sectional study. Alzheimers Res Ther. 2023;15(1):97.
Article CAS PubMed PubMed Central Google Scholar
Pålhaugen L, Sudre CH, Tecelao S, Nakling A, Almdahl IS, Kalheim LF, et al. Brain amyloid and vascular risk are related to distinct white matter hyperintensity patterns. J Cereb Blood Flow Metab. 2021;41(5):1162–74.
Fatemi F, Kantarci K, Graff-Radford J, Preboske GM, Weigand SD, Przybelski SA, et al. Sex differences in cerebrovascular pathologies on FLAIR in cognitively unimpaired elderly. Neurology. 2018;90(6):e466–73.
Article PubMed PubMed Central Google Scholar
Lohner V, Pehlivan G, Sanroma G, Miloschewski A, Schirmer MD, Stöcker T, et al. Relation between sex, menopause, and white matter hyperintensities: the Rhineland Study. Neurology. 2022;99(9):e935–43.
Article CAS PubMed PubMed Central Google Scholar
Rostrup E, Gouw AA, Vrenken H, van Straaten EC, Ropele S, Pantoni L, et al. The spatial distribution of age-related white matter changes as a function of vascular risk factors–results from the LADIS study. Neuroimage. 2012;60(3):1597–607.
Article CAS PubMed Google Scholar
Kloppenborg RP, Nederkoorn PJ, Geerlings MI, Berg E. Presence and progression of white matter hyperintensities and cognition. A meta-analysis. Neurology. 2014;82(23):2127–38.
Bolandzadeh N, Davis JC, Tam R, Handy TC, Liu-Ambrose T. The association between cognitive function and white matter lesion location in older adults: a systematic review. BMC Neurol. 2012;12(1):126.
Article PubMed PubMed Central Google Scholar
Yoshita M, Fletcher E, Harvey D, Ortega M, Martinez O, Mungas DM, et al. Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD. Neurology. 2006;67(12):2192–8.
Article CAS PubMed Google Scholar
Vemuri P, Lesnick TG, Przybelski SA, Knopman DS, Preboske GM, Kantarci K, et al. Vascular and amyloid pathologies are independent predictors of cognitive decline in normal elderly. Brain. 2015;138(Pt 3):761–71.
Article PubMed PubMed Central Google Scholar
Jorgensen DR, Shaaban CE, Wiley CA, Gianaros PJ, Mettenburg J, Rosano C. A population neuroscience approach to the study of cerebral small vessel disease in midlife and late life: an invited review. Am J Physiol Heart Circ Physiol. 2018;314(6):H1117–36.
Article CAS PubMed PubMed Central Google Scholar
Moroni F, Ammirati E, Hainsworth AH, Camici PG. Association of white matter hyperintensities and cardiovascular disease. Circ Cardiovasc Imaging. 2020;13(8):e010460.
Vemuri P, Davey C, Johansen KL, Zuk SM, Reid RI, Thostenson KB, et al. Chronic kidney disease associated with worsening white matter disease and ventricular enlargement. J Alzheimers Dis. 2021;83(4):1729–40.
Article CAS PubMed PubMed Central Google Scholar
Guo X, Pantoni L, Simoni M, Gustafson D, Bengtsson C, Palmertz B, et al. Midlife respiratory function related to white matter lesions and lacunar infarcts in late life. Stroke. 2006;37(7):1658–62.
Zacharias HU, Weihs A, Habes M, Wittfeld K, Frenzel S, Rashid T, et al. Association between obstructive sleep apnea and brain white matter hyperintensities in a population-based cohort in Germany. JAMA Netw Open. 2021;4(10):e2128225–e.
Article PubMed PubMed Central Google Scholar
Noh J, Kim HC, Shin A, Yeom H, Jang SY, Lee JH, et al. Prevalence of comorbidity among people with hypertension: the Korea national health and nutrition examination survey 2007–2013. Korean Circ J. 2016;46(5):672–80.
Article PubMed PubMed Central Google Scholar
Sudre CH, Gomez Anson B, Davagnanam I, Schmitt A, Mendelson AF, Prados F, et al. Bullseye’s representation of cerebral white matter hyperintensities. J Neuroradiol. 2018;45(2):114–22.
Article CAS PubMed PubMed Central Google Scholar
Bachmann D, Roman ZJ, Buchmann A, Zuber I, Studer S, Saake A, et al. Lifestyle affects amyloid burden and cognition differently in men and women. Ann Neurol. 2022;92(3):451–63.
Article CAS PubMed PubMed Central Google Scholar
Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, et al. Mild cognitive impairment–beyond controversies, towards a consensus: report of the International Working Group on mild cognitive impairment. J Intern Med. 2004;256(3):240–6.
Article CAS PubMed Google Scholar
Bachmann D, Buchmann A, Studer S, Saake A, Rauen K, Zuber I, et al. Age-, sex-, and pathology-related variability in brain structure and cognition. Translational Psychiatry. 2023;13(1):278.
Article CAS PubMed PubMed Central Google Scholar
Fischl B. FreeSurfer. Neuroimage. 2012;62(2):774–81.
Cox RW. AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Comput Biomed Res. 1996;29(3):162–73.
Article CAS PubMed Google Scholar
Jenkinson M, Beckmann CF, Behrens TE, Woolrich MW, Smith SM. FSL. Neuroimage. 2012;62(2):782–90.
Klein A, Tourville J. 101 labeled brain images and a consistent human cortical labeling protocol. Front NeuroSci. 2012;6.
Article PubMed PubMed Central Google Scholar
Garnier-Crussard A, Bougacha S, Wirth M, Dautricourt S, Sherif S, Landeau B, et al. White matter hyperintensity topography in Alzheimer’s disease and links to cognition. Alzheimer’s Dement. 2022;18(3):422–33.
Vemuri P, Lesnick TG, Przybelski SA, Graff-Radford J, Reid RI, Lowe VJ, et al. Development of a cerebrovascular magnetic resonance imaging biomarker for cognitive aging. Ann Neurol. 2018;84(5):705–16.
Article PubMed PubMed Central Google Scholar
Valenzuela MJ, Sachdev P. Assessment of complex mental activity across the lifespan: development of the Lifetime of Experiences Questionnaire (LEQ). Psychol Med. 2007;37(7):1015–25.
留言 (0)